Drug intelligence / Profile preview

KS99

Development stage
Preclinical
Lead developer
The Pennsylvania State University
Modality
Small Molecules
01

Overview

KS99 is a synthetic isatin analog, specifically 5,7-dibromo-N-(p-thiocyanomethylbenzyl)isatin, developed by researchers at Pennsylvania State University for the treatment of various hematological and solid malignancies. It acts as a multi-target inhibitor, targeting Bruton tyrosine kinase (BTK), AKT, and tubulin polymerization. In preclinical studies, KS99 has demonstrated potent cytotoxic activity against acute myeloid leukemia (AML) cell lines and primary patient samples by inducing apoptosis through the modulation of Mcl-1 and Bcl-2 expression. It has also shown efficacy against multiple myeloma and several solid tumor models.

Other names
5,7-dibromo-N-(p-thiocyanomethylbenzyl)isatin
02

Targets

ALDH1A1 (Aldehyde dehydrogenase 1 family member A1)BTK (Bruton tyrosine kinase)STAT3 (Signal Transducer and Activator of Transcription 3)AKT (RAC-alpha serine/threonine-protein kinase)TUBB (Tubulin (alpha and beta subunits))

Beyond the preview

Go deeper on KS99.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on KS99.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call